Tappy L, Le K A. Metabolic effects of fructose and the worldwide increase in obesity[J]. Physiol Rev, 2010, 90(1):？ 23-46. [2]Taylor E N, Curhan G C. Fructose consumption and the risk of kidney stones[J]. Kidney Int, 2007, 73(2):？ 207-212. [3]Apontes P, Liu Z, Su K, et al. Mangiferin stimulates carbohydrate oxidation and protects against metabolic disorders induced by high-fat diets[J]. Diabetes, 2014, 63(11):？ 3626-3636. [4]Wang H L, Li C Y, Zhang B, et al. Mangiferin facilitates islet regeneration and β-cell proliferation through upregulation of cell cycle and β-cell regeneration regulators[J]. Int J Mol Sci, 2014, 15(5):？ 9016-9035. [5]Kavitha M, Manivasagam T, Essa M M, et al. Mangiferin antagonizes rotenone:？ induced apoptosis through attenuating mitochondrial dysfunction and oxidative stress in SK-N-SH neuroblastoma cells[J]. Neurochem Res, 2014, 39(4):？ 668-676. [6]Pal P B, Sinha K, Sil P C. Mangiferin attenuates diabetic nephropathy by inhibiting oxidative stress mediated signaling cascade, TNFα related and mitochondrial dependent apoptotic pathways in streptozotocin-induced diabetic rats[J]. PLoS One, 2014, 9(9):？ e107220. [7]周智, 吴植强, 韦奇志, 等. 芒果苷对神经、呼吸和心血管系统的影响及其急性毒性研究[J]. 中国中医药科技, 2011, 18(4):？ 328-329. [8]邱水晶, 刘义, 杜红禹. 芒果苷对糖尿病大鼠肾脏的保护作用及机制[J]. 中国动脉硬化杂志, 2010, 18(12):？ 956-960. [9]Gao H, Guan T, Li C, et al. Treatment with ginger ameliorates fructose-induced fatty liver and hypertriglyceridemia in rats:？ modulation of the hepatic carbohydrate response element-binding protein-mediated pathway[J]. Evid Based Complement Alternat Med, 2012, 2012: 570948. [10]Xing X, Li D, Chen D, et al. Mangiferin treatment inhibits hepatic expression of acyl-coenzyme A:？ diacylglycerol acyltransferase-2 in fructose-fed spontaneously hypertensive rats:？ a link to amelioration of fatty liver[J]. Toxicol Appl Pharmacol, 2014, 280(2):？ 207-215. [11]Rangan G K, Wang Y, Tay Y C, et al. Inhibition of nuclear factor-kappaB activation reduces cortical tubulointerstitial injury in proteinuric rats[J]. Kidney Int , 1999, 56(1): 118-134. [12]Eitner F, Floege J. Novel insights into renal fibrosis[J]. Curr Opin Nephrol Hypertens, 2003, 12(3): 227-232. [13]Cheng H, Chen C, Wang S, et al. The effects of urokinase-type plasminogen activator (uPA) on cell proliferation and phenotypic transformation of rat mesangial cells induced by high glucose[J]. Diabetes Res Clin Pract, 2014, 103(3):？ 489-495. [14]Lee J H, Oh M H, Park J S, et al. Urokinase, urokinase receptor, and plasminogen activator inhibitor-1 expression on podocytes in immunoglobulin A glomerulonephritis[J]. Korean J Intern Med, 2014, 29(2):？ 176-182. [15]Nicholas S B, Kawano Y, Wakino S, et al. Expression and function of peroxisome proliferator-activated receptor-γ in mesangial cells[J]. Hypertension, 2001, 37(2 Pt 2):？ 722-727. [16]胡志娟, 任路平, 王超, 等. 鹅去氧胆酸对高果糖喂养致大鼠脂质肾毒性中纤维化、炎症和氧化应激的影响[J]. 中国老年学杂志, 2014, 34(11): 3088-3091. [17]齐延飞. ZDF大鼠糖尿病肾病发病机制的确立及五层龙的治疗作用[D]. 长春: 吉林大学, 2007. ？
